Aurobindo Pharma Ltd's subsidiary to withdraw application for EU Marketing Authorization of two biosimilars
EMA | 26/06/2023 | By Sudeep Soparkar | 487
WuXi Biologics' drug substance and drug product facilities bags US FDA, EMA approval
These approvals add to the previous 25 certifications from more than 10 global regulatory administrations
EMA | 20/09/2022 | By Sudeep Soparkar | 406
EMA reviews gene therapy for Haemophilia B
EMA (European Medicines Agency) has started reviewing the CSL Behring's MAA for gene therapy etranacogene dezaparvovec (EtranaDez), for the patients getting treatment for Haemophila B.
EMA | 28/04/2022 | By Sudeep Soparkar | 611
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy